Search research articles
Contact Us
Filters
Showing results (31-40 of 66) with videos related to
Page
of 7
Sort By:
Annals of Hematology
|
April 3, 2024
Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study
Lucía Pérez-Lamas, Raquel de Paz Arias, Rosa Mª Ayala Díaz, et al.
Frontiers in Medicine
|
February 27, 2023
Familial CD45RA<sup>-</sup> T cells to treat severe refractory infections in immunocompromised patients
Karima Al-Akioui Sanz, Carlos Echecopar Parente, Cristina Ferreras, et al.
Cytotherapy
|
July 24, 2024
Safety and Efficacy of High-Dose Memory CD45RO<sup>+</sup> Donor Lymphocyte Infusion in Pediatric Recipients after Hematopoietic Stem Cell Transplantation
Mercedes Gasior Kabat, Ying Li, Victor Galán, et al.
Transfusion
|
March 13, 2021
The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus-6B encephalitis after naïve T-cell-depleted allogeneic stem cell transplantation
Mercedes Gasior, Cristina Ferreras, Raquel de Paz, et al.
American Journal of Hematology
|
June 15, 2017
Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group
Fernando Ramos, Cristina Robledo, Arturo Pereira, et al.
American Journal of Hematology
|
November 19, 2016
Excess mortality in the myelodysplastic syndromes
Meritxell Nomdedeu, Arturo Pereira, Fernando Ramos, et al.
Blood Advances
|
June 21, 2022
Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML
Lionel Adès, Larisa Girshova, Vadim A Doronin, et al.
Annals of Hematology
|
August 10, 2012
Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival
Carlos Santamaría, Fernando Ramos, Noemi Puig, et al.
Cancer Medicine
|
March 11, 2015
Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months
Luis-Felipe Casado, José-Valentín García-Gutiérrez, Isabel Massagué, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 16, 2013
Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation
Jaime Sanz, Alessandra Picardi, Juan C Hernández Boluda, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 66) with videos related to
Sort By:
Page
of 7
Annals of Hematology
|
April 3, 2024
Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study
Lucía Pérez-Lamas, Raquel de Paz Arias, Rosa Mª Ayala Díaz, et al.
Frontiers in Medicine
|
February 27, 2023
Familial CD45RA<sup>-</sup> T cells to treat severe refractory infections in immunocompromised patients
Karima Al-Akioui Sanz, Carlos Echecopar Parente, Cristina Ferreras, et al.
Cytotherapy
|
July 24, 2024
Safety and Efficacy of High-Dose Memory CD45RO<sup>+</sup> Donor Lymphocyte Infusion in Pediatric Recipients after Hematopoietic Stem Cell Transplantation
Mercedes Gasior Kabat, Ying Li, Victor Galán, et al.
Transfusion
|
March 13, 2021
The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus-6B encephalitis after naïve T-cell-depleted allogeneic stem cell transplantation
Mercedes Gasior, Cristina Ferreras, Raquel de Paz, et al.
American Journal of Hematology
|
June 15, 2017
Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group
Fernando Ramos, Cristina Robledo, Arturo Pereira, et al.
American Journal of Hematology
|
November 19, 2016
Excess mortality in the myelodysplastic syndromes
Meritxell Nomdedeu, Arturo Pereira, Fernando Ramos, et al.
Blood Advances
|
June 21, 2022
Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML
Lionel Adès, Larisa Girshova, Vadim A Doronin, et al.
Annals of Hematology
|
August 10, 2012
Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival
Carlos Santamaría, Fernando Ramos, Noemi Puig, et al.
Cancer Medicine
|
March 11, 2015
Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months
Luis-Felipe Casado, José-Valentín García-Gutiérrez, Isabel Massagué, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 16, 2013
Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation
Jaime Sanz, Alessandra Picardi, Juan C Hernández Boluda, et al.
Page
of 7